FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367297729> ?p ?o ?g. }

• W4367297729 endingPage "100243" @default.
• W4367297729 startingPage "100243" @default.
• W4367297729 abstract "The phase-3 MONALEESA-2, -3 and -7 randomized trials showed benefit of CDK4/6 inhibitor, ribociclib, in women with advanced-stage breast cancer. However, ribociclib-induced acute kidney injury (AKI) was not addressed in these studies. In this report, we explore AKI in breast cancer patients receiving ribociclib. Medical records of all breast cancer patients who received ribociclib at our institution between April 2019 and September 2021 were reviewed. Details of creatinine kinetics in relation to ribociclib administration and other nephrotoxic drugs were obtained. Acute kidney injury grades (AKI-KDIGO classification) were captured. 154 females, with advanced-stage breast cancer treated with aromatase inhibitors (AI) or fulvestrant plus ribociclib were reviewed. A total of 29 (18.8%) patients developed AKI; 5 were grade-I, 21 grade-II and 3 were grade-III. Rate of AKI was significantly higher (n = 16, 45.7%) among 35 patients who were on other concomitant nephrotoxic drugs, compared to 11 (9.6%) of 114 other patients, p = 0.001. Median time to develop AKI was 54 (range, 21–168) days, while the median time for creatinine recovery was 5 (range, 4–7) days after holding the drugs. Average creatinine increment for affected patients was 2.28 times the baseline level. Time to AKI was sooner, but not statistically significant, among patients on nephrotoxic drugs and recovery was faster after stopping these drugs. Ribociclib-induced AKI is not uncommon and not adequately addressed. Though reversible in majority of patients, some patients may develop grade-III AKI or require treatment interruption. Nephrotoxic drugs seem to significantly enhance ribociclib-associated renal injury, withholding these drugs and close follow up is strongly recommended. Prospective studies are warranted to validate these conclusions." @default.
• W4367297729 created "2023-04-29" @default.
• W4367297729 creator A5002553471 @default.
• W4367297729 creator A5012397040 @default.
• W4367297729 creator A5032290025 @default.
• W4367297729 creator A5033542956 @default.
• W4367297729 creator A5089675528 @default.
• W4367297729 date "2023-09-01" @default.
• W4367297729 modified "2023-10-18" @default.
• W4367297729 title "Ribociclib-induced acute kidney injury in patients with advanced-stage breast cancer: A case series and literature review" @default.
• W4367297729 cites W2023926251 @default.
• W4367297729 cites W2032967535 @default.
• W4367297729 cites W2047073502 @default.
• W4367297729 cites W2118728607 @default.
• W4367297729 cites W2127286421 @default.
• W4367297729 cites W2148096512 @default.
• W4367297729 cites W2513801928 @default.
• W4367297729 cites W2528767298 @default.
• W4367297729 cites W2552099557 @default.
• W4367297729 cites W2605858714 @default.
• W4367297729 cites W2617437931 @default.
• W4367297729 cites W2765248184 @default.
• W4367297729 cites W2802776309 @default.
• W4367297729 cites W2948069739 @default.
• W4367297729 cites W2952762910 @default.
• W4367297729 cites W2956031258 @default.
• W4367297729 cites W2965020061 @default.
• W4367297729 cites W2983704073 @default.
• W4367297729 cites W3156413366 @default.
• W4367297729 cites W3216253742 @default.
• W4367297729 cites W4211005384 @default.
• W4367297729 cites W4285043187 @default.
• W4367297729 cites W4297537212 @default.
• W4367297729 doi "https://doi.org/10.1016/j.cpccr.2023.100243" @default.
• W4367297729 hasPublicationYear "2023" @default.
• W4367297729 type Work @default.
• W4367297729 citedByCount "0" @default.
• W4367297729 crossrefType "journal-article" @default.
• W4367297729 hasAuthorship W4367297729A5002553471 @default.
• W4367297729 hasAuthorship W4367297729A5012397040 @default.
• W4367297729 hasAuthorship W4367297729A5032290025 @default.
• W4367297729 hasAuthorship W4367297729A5033542956 @default.
• W4367297729 hasAuthorship W4367297729A5089675528 @default.
• W4367297729 hasBestOaLocation W43672977291 @default.
• W4367297729 hasConcept C121608353 @default.
• W4367297729 hasConcept C126189478 @default.
• W4367297729 hasConcept C126322002 @default.
• W4367297729 hasConcept C126894567 @default.
• W4367297729 hasConcept C141071460 @default.
• W4367297729 hasConcept C143998085 @default.
• W4367297729 hasConcept C146357865 @default.
• W4367297729 hasConcept C151730666 @default.
• W4367297729 hasConcept C2777176818 @default.
• W4367297729 hasConcept C2779384505 @default.
• W4367297729 hasConcept C2780091579 @default.
• W4367297729 hasConcept C2780306776 @default.
• W4367297729 hasConcept C2780472472 @default.
• W4367297729 hasConcept C2780482068 @default.
• W4367297729 hasConcept C530470458 @default.
• W4367297729 hasConcept C71924100 @default.
• W4367297729 hasConcept C86803240 @default.
• W4367297729 hasConceptScore W4367297729C121608353 @default.
• W4367297729 hasConceptScore W4367297729C126189478 @default.
• W4367297729 hasConceptScore W4367297729C126322002 @default.
• W4367297729 hasConceptScore W4367297729C126894567 @default.
• W4367297729 hasConceptScore W4367297729C141071460 @default.
• W4367297729 hasConceptScore W4367297729C143998085 @default.
• W4367297729 hasConceptScore W4367297729C146357865 @default.
• W4367297729 hasConceptScore W4367297729C151730666 @default.
• W4367297729 hasConceptScore W4367297729C2777176818 @default.
• W4367297729 hasConceptScore W4367297729C2779384505 @default.
• W4367297729 hasConceptScore W4367297729C2780091579 @default.
• W4367297729 hasConceptScore W4367297729C2780306776 @default.
• W4367297729 hasConceptScore W4367297729C2780472472 @default.
• W4367297729 hasConceptScore W4367297729C2780482068 @default.
• W4367297729 hasConceptScore W4367297729C530470458 @default.
• W4367297729 hasConceptScore W4367297729C71924100 @default.
• W4367297729 hasConceptScore W4367297729C86803240 @default.
• W4367297729 hasLocation W43672977291 @default.
• W4367297729 hasOpenAccess W4367297729 @default.
• W4367297729 hasPrimaryLocation W43672977291 @default.
• W4367297729 hasRelatedWork W1531799488 @default.
• W4367297729 hasRelatedWork W174477127 @default.
• W4367297729 hasRelatedWork W1981276500 @default.
• W4367297729 hasRelatedWork W2000318260 @default.
• W4367297729 hasRelatedWork W2037115108 @default.
• W4367297729 hasRelatedWork W2061923809 @default.
• W4367297729 hasRelatedWork W2093874596 @default.
• W4367297729 hasRelatedWork W2127896754 @default.
• W4367297729 hasRelatedWork W2352513935 @default.
• W4367297729 hasRelatedWork W2414630804 @default.
• W4367297729 hasVolume "11" @default.
• W4367297729 isParatext "false" @default.
• W4367297729 isRetracted "false" @default.
• W4367297729 workType "article" @default.